Peptide Hormones and Follicle Development

Reproductive Peptides

4 peptides

Four peptide hormones form a cascade from brain to ovary: kisspeptin triggers GnRH, which releases FSH and LH, driving every stage of follicle development.

Xie et al., Frontiers in Endocrinology, 2022

Xie et al., Frontiers in Endocrinology, 2022

View as image

Every ovarian follicle that matures, every egg that ovulates, and every corpus luteum that forms depends on a chain of peptide signals running from the hypothalamus to the pituitary to the ovary. This hypothalamic-pituitary-gonadal (HPG) axis is controlled by four peptide hormones: kisspeptin initiates the cascade, gonadotropin-releasing hormone (GnRH) relays it, and follicle-stimulating hormone (FSH) and luteinizing hormone (LH) execute it at the ovary. Understanding how this peptide signaling system governs follicle development is central to reproductive medicine, from diagnosing infertility to designing IVF protocols.

The Cascade: From Brain to Ovary

The reproductive peptide cascade operates in a strict hierarchy. Each peptide triggers the next, and feedback loops from the ovary regulate the entire system.

Step 1: Kisspeptin. Neurons in two hypothalamic regions, the arcuate nucleus (ARC) and the anteroventral periventricular nucleus (AVPV), secrete kisspeptin. This peptide binds to its receptor (KISS1R, also called GPR54) on GnRH neurons.^[1] Kisspeptin was identified as the upstream controller of GnRH in 2003, when researchers discovered that loss-of-function mutations in KISS1R caused a complete failure of puberty and reproductive function.

Step 2: GnRH. Kisspeptin stimulation causes GnRH neurons to release gonadotropin-releasing hormone, a 10-amino-acid peptide, into the portal blood vessels connecting the hypothalamus to the anterior pituitary. GnRH release is pulsatile, not continuous, and the pulse frequency determines which gonadotropin the pituitary preferentially secretes.^[2]

Step 3: FSH and LH. GnRH binds to its receptor on pituitary gonadotroph cells, triggering secretion of FSH and LH. These glycoprotein hormones enter systemic circulation and act on the ovary to drive follicle development, steroid hormone production, and ovulation.

Step 4: Ovarian response and feedback. Ovarian hormones (estradiol, progesterone, inhibin) feed back to the hypothalamus and pituitary, modulating kisspeptin and GnRH release. This closed loop ensures that follicle development is tightly coordinated with hormonal status.

The KNDy Neuron: Generating the Pulse

The pulsatile nature of GnRH release is essential. Continuous GnRH exposure desensitizes pituitary receptors and shuts down gonadotropin secretion, which is why GnRH agonists paradoxically suppress rather than stimulate reproduction when given continuously.

The pulse generator was identified as a population of neurons in the arcuate nucleus that co-express three neuropeptides: kisspeptin, neurokinin B (NKB), and dynorphin. These "KNDy neurons" regulate their own firing through autosynaptic feedback.^[1] NKB stimulates kisspeptin release from neighboring KNDy neurons, while dynorphin inhibits it. This push-pull mechanism generates rhythmic pulses of kisspeptin secretion, which in turn drive pulsatile GnRH release.

Skorupskaite and colleagues described how this system works in humans: "Following paracrine stimulatory and inhibitory inputs from neurokinin B and dynorphin, [KNDy neurons] signal directly to GnRH neurones to control pulsatile GnRH release."^[1] When kisspeptin is administered to humans, it robustly stimulates LH secretion and increases LH pulse frequency, confirming that kisspeptin sits upstream of the entire cascade.

GnRH Pulse Frequency Determines FSH vs. LH

GnRH doesn't simply turn gonadotropins on or off. The frequency of GnRH pulses determines which gonadotropin the pituitary preferentially releases. Slow pulses (approximately every 2-4 hours) favor FSH secretion. Fast pulses (every 60-90 minutes) favor LH secretion.^[3]

This frequency coding has direct consequences for follicle development:

• Early follicular phase: Slow GnRH pulses produce relatively more FSH, recruiting a cohort of antral follicles from the ovarian reserve
• Late follicular phase: As estradiol rises from growing follicles, GnRH pulse frequency increases, shifting the balance toward LH, which drives final follicle maturation
• Preovulatory period: A massive positive feedback surge of estrogen triggers the AVPV kisspeptin neurons to produce a burst of kisspeptin, driving the GnRH/LH surge that triggers ovulation

Millar and Newton reviewed how this understanding has been exploited therapeutically: GnRH agonists and antagonists are used extensively in IVF to control the timing and magnitude of gonadotropin release, while kisspeptin and NKB analogs represent the next generation of reproductive therapeutics that modulate the cascade upstream of GnRH.^[3]

FSH: Recruiting and Growing Follicles

FSH is the primary driver of follicular recruitment and growth. Each menstrual cycle, a rise in FSH rescues a cohort of antral follicles from atresia (programmed death) and stimulates their granulosa cells to proliferate, produce estradiol, and express LH receptors in preparation for ovulation.

FSH acts through the FSH receptor (FSHR) expressed exclusively on granulosa cells. Receptor activation triggers multiple intracellular pathways: cAMP/PKA signaling drives aromatase expression (the enzyme that converts androgens to estrogens), while PI3K/Akt signaling promotes cell survival and proliferation.^[4]

The "FSH window" is a critical concept in reproductive biology. Only follicles with sufficient FSHR expression survive when FSH levels rise above the threshold. As one follicle outgrows its cohort and produces more estradiol and inhibin B, it drives FSH levels back down through negative feedback, causing smaller follicles to undergo atresia. This is how a single dominant follicle is selected from the initial cohort.

Recombinant FSH (follitropin alfa, follitropin beta) is the backbone of controlled ovarian stimulation in IVF. By injecting supraphysiologic doses of FSH, clinicians rescue multiple follicles from atresia simultaneously, producing the multiple eggs needed for assisted reproduction.

LH: Maturation and the Ovulatory Trigger

While FSH builds the follicle, LH drives its final maturation and triggers ovulation. In the preovulatory follicle, LH acts on both theca cells (stimulating androgen production) and granulosa cells that have acquired LH receptors under FSH influence.

The LH surge, typically lasting 48-72 hours, initiates a cascade of events within the dominant follicle: resumption of meiosis in the oocyte (which has been arrested since fetal life), cumulus cell expansion, follicular wall breakdown, and extrusion of the mature egg.^[2]

Masumi and colleagues highlighted that the LH surge triggers not only central mechanisms (via the HPG axis) but also local signaling within the ovary. The surge causes granulosa cells to upregulate kisspeptin expression locally, and kisspeptin receptors are expressed directly on oocytes. Loss of these oocyte kisspeptin receptors in mice produces a phenotype resembling premature ovarian insufficiency, with failure of oocyte maturation and ovulation.^[2]

This dual role of kisspeptin, acting both centrally (driving GnRH secretion) and locally within the ovary (promoting oocyte maturation), adds complexity to the reproductive cascade and opens therapeutic possibilities for kisspeptin-based interventions.

Estrogen Feedback: Two Populations, Two Signals

The feedback loop that connects the ovary back to the hypothalamus operates through estrogen's effects on kisspeptin neurons. Xie and colleagues described how two anatomically distinct populations of kisspeptin neurons mediate opposite responses to estrogen.^[4]

Arcuate nucleus kisspeptin neurons are suppressed by estrogen. These neurons maintain tonic (baseline) GnRH pulsatility. When estrogen rises from growing follicles, arcuate kisspeptin secretion decreases, slowing GnRH pulses. This negative feedback prevents premature LH surges and excess follicle recruitment.

AVPV kisspeptin neurons are stimulated by estrogen. When estradiol from the dominant follicle reaches a sustained high level (typically above 200 pg/mL for 36-48 hours), it switches from negative to positive feedback, activating AVPV kisspeptin neurons. The resulting burst of kisspeptin drives the preovulatory GnRH/LH surge that triggers ovulation.

This dual-population model explains one of reproductive biology's oldest puzzles: how the same hormone (estrogen) can both suppress and stimulate LH secretion depending on its concentration and duration of exposure.

Kisspeptin in Clinical Applications

The discovery of kisspeptin's role as the master switch of the reproductive cascade has generated interest in therapeutic applications. Khan and colleagues reviewed kisspeptin's diagnostic and therapeutic potential in 2021, noting that plasma kisspeptin levels may serve as biomarkers for HPG axis function in conditions like hypothalamic amenorrhea, PCOS, and central precocious puberty.^[5]

In IVF, kisspeptin-54 has been administered to trigger oocyte maturation as an alternative to hCG or GnRH agonist triggers. The rationale: kisspeptin produces a more physiologic LH surge than exogenous hCG, with a shorter duration that reduces the risk of ovarian hyperstimulation syndrome (OHSS). Early clinical trials showed that kisspeptin-54 successfully triggered oocyte maturation with minimal OHSS risk, even in high-responder patients.

For hypogonadotropic hypogonadism, kisspeptin administration can restore pulsatile LH secretion, offering a potential alternative to exogenous gonadotropin therapy that maintains the physiologic pulse pattern rather than delivering continuous hormonal stimulation.

When the Cascade Breaks Down

Disruptions at any level of the cascade produce distinct clinical phenotypes:

Kisspeptin/KISS1R mutations cause isolated hypogonadotropic hypogonadism: no puberty, no gonadotropin secretion, infertility. These patients respond to exogenous GnRH, confirming the defect is upstream.

GnRH deficiency (Kallmann syndrome and related conditions) produces the same phenotype. Patients have intact pituitaries but lack the GnRH signal. Pulsatile GnRH pump therapy can restore fertility.

FSH receptor mutations cause primary ovarian insufficiency with elevated gonadotropins (the pituitary works but the ovary can't respond). This is distinct from central causes.

Polycystic ovary syndrome (PCOS) involves increased GnRH pulse frequency, elevated LH relative to FSH, and disrupted follicle selection. The dominant follicle fails to emerge, leaving multiple small antral follicles. Kisspeptin neurons may be hyperactive in PCOS, contributing to the elevated LH pulse frequency.

Each of these disruptions highlights a different node in the peptide cascade and guides specific therapeutic strategies: upstream kisspeptin or GnRH therapy for central defects, exogenous gonadotropins for pituitary failure, and GnRH pulse-frequency modulation for PCOS.

The Bottom Line

Ovarian follicle development depends on a four-peptide cascade: kisspeptin activates GnRH neurons, GnRH drives pulsatile FSH and LH release, and these gonadotropins execute follicle recruitment, maturation, and ovulation at the ovary. The pulse frequency of GnRH determines the FSH-to-LH ratio, and estrogen feedback through two distinct kisspeptin neuron populations creates the switch between tonic suppression and the preovulatory LH surge. Clinical applications of this cascade include GnRH agonists/antagonists in IVF, kisspeptin as an ovulatory trigger, and targeted interventions at each level for specific reproductive disorders.

Frequently Asked Questions

What peptide hormones control follicle development?

Four peptide hormones form the cascade: kisspeptin (from the hypothalamus) triggers GnRH release, GnRH (a 10-amino-acid peptide) stimulates the pituitary to secrete FSH and LH, and these gonadotropins act directly on the ovary to recruit follicles (FSH), produce estrogen, and trigger ovulation (LH). The entire system is regulated by estrogen and progesterone feedback from the ovary (Xie et al., 2022).

What is kisspeptin and why does it matter for fertility?

Kisspeptin is a hypothalamic peptide that acts as the master switch of the reproductive hormone cascade. It binds to KISS1R receptors on GnRH neurons, controlling pulsatile GnRH release. Loss of kisspeptin or its receptor causes failure of puberty and infertility. Kisspeptin is now being tested as an IVF trigger that produces a more physiologic ovulatory response than standard treatments (Skorupskaite et al., 2014).

How does GnRH pulse frequency affect reproduction?

GnRH is released in pulses, not continuously. Slow pulses (every 2-4 hours) favor FSH secretion, which recruits follicles. Fast pulses (every 60-90 minutes) favor LH secretion, which drives final maturation and ovulation. This frequency coding is generated by KNDy neurons in the arcuate nucleus that co-express kisspeptin, neurokinin B, and dynorphin (Millar & Newton, 2013).

Why are GnRH agonists used in IVF?

Continuous GnRH agonist administration initially stimulates but then desensitizes pituitary GnRH receptors, shutting down FSH and LH production. This "medical castration" prevents premature LH surges during controlled ovarian stimulation, allowing clinicians to time ovulation precisely. GnRH antagonists achieve the same goal faster, blocking the receptor directly without the initial stimulation phase (Millar & Newton, 2013).

What role does kisspeptin play in the ovary itself?

Beyond its central role in the brain, kisspeptin acts directly within the ovary. Granulosa cells produce kisspeptin, and kisspeptin receptors are expressed on oocytes. In mice, loss of oocyte kisspeptin receptors causes premature ovarian insufficiency with failed oocyte maturation and ovulation. This local kisspeptin signaling may work alongside the central cascade to coordinate follicle development (Masumi et al., 2022).

What happens when the reproductive peptide cascade breaks down?

Disruptions at different levels produce distinct conditions. Kisspeptin or GnRH deficiency causes hypogonadotropic hypogonadism (no puberty, no fertility). FSH receptor mutations cause primary ovarian insufficiency. In PCOS, increased GnRH pulse frequency elevates LH relative to FSH, disrupting follicle selection and preventing dominant follicle emergence. Treatment strategies target the specific level of the cascade that is disrupted.